Cel Sci Corporation (CVM): $CVM CEL-SCI’s Head and Neck Cancer Regi...

$CVM CEL-SCI’s Head and Neck Cancer Registration Study

Budots · 2025-03-17T15:51:59.3300000Z

$CVM CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine https://finance.yahoo.com/news/cel-sci-head-neck-cancer-120000661.html

Play Episode

6min

Proactive - Interviews for investors

Rainbow Rare Earths CEO George Bennett: Rainbow’s plan for an independent rare earth supply

Rainbow Rare Earths CEO George Bennett joined Steve Darling from Proactive to discuss the company’s latest milestones, including a $50 million investment from the U.S. International Development Finance Corporation (DFC). This funding reinforces Rainbow’s strategic position as a leading rare earth producer, extracting critical minerals from phosphor gypsum waste in South Africa. Bennett highlighted the growing demand for rare earth elements, essential for electric vehicles, wind turbines, robotics, and drones. With China dominating rare earth processing and rising geopolitical tensions, he stressed the urgent need for an independent supply chain to support North America, Europe, and key Asian markets. Rainbow is advancing its operations with the relocation of its pilot separation work to Johannesburg, where the company is refining its leaching process to achieve high-purity production. The definitive feasibility study remains on track for completion by the end of 2025, further strengthening Rainbow’s market position. Bennett emphasized that Rainbow’s planned production of 2,000 tons of high-value rare earth oxides will be a major step toward diversifying the global supply chain, reducing dependence on Chinese processing, and ensuring a sustainable, high-margin alternative for critical mineral resources. #proactiveinvestors #rainbowrareearthslimited #lse #rbw #otc #rbwrf #CleanEnergy #ElectricVehicles #CriticalMinerals #GreenMining #RainbowRareEarths #SupplyChain #USInvestment #TechMaterials

Proactive - Interviews for investors

AXP Energy expands financial mining operations with BitFuFu partnership

AXP Energy Managing Director Dan Lanskey joined Steve Darling from Proactive to announce the successful completion of the company’s initial gas-to-power trial at the Pathfinder production hub in Colorado. Over a 14-day period, AXP delivered 1.5 MW/hour of electricity with 85% uptime, supporting efficient bitcoin mining operations. Following system optimizations, uptime has now exceeded 90%, marking a significant milestone for the project. AXP has secured the backing of NASDAQ-listed BitFuFu, Inc., through its joint venture partner, to advance the next phase of bitcoin mining expansion at the Pathfinder Field. The site, which has a steady supply of natural gas from AXP’s 24 wells, holds further production potential to support large-scale mining operations. Looking ahead, AXP is targeting the phased delivery of 25 MW of electricity by the end of 2025. The next immediate step is expanding the first site to 5 MW, with BitFuFu supplying additional ASIC miners and equipment. Beyond the Pathfinder Field, AXP and BitFuFu are also exploring additional opportunities across North America, with AXP serving as the primary energy provider for future mining projects. #proactiveinvestors #axpenergylimited #asx #axp #otc #aunxf #BitcoinMining #OilAndGas #CryptoEnergy #BitFuFu #StrandedGas #EnergyInnovation #OffGridPower #CryptoMining #RenewableEnergy #Nasdaq #EnergyMarkets #Investment #OilProduction

Proactive - Interviews for investors

Aftermath Silver strengthens leadership with strategic advisor Danny Keating

Aftermath Silver CEO Ralph Rushton joined Steve Darling from Proactive to announce the appointment of Danny Keating as a strategic advisor to the company. Keating brings over 30 years of experience in mining, processing, and infrastructure development, having led major projects across multiple jurisdictions. Most recently, Keating spearheaded the development of a High Purity Manganese project in Southern Africa, where he oversaw the construction of an EV battery demonstration plant and successfully secured strategic investors. His deep understanding of the battery market and evolving battery chemistries will be instrumental in guiding Aftermath Silver’s strategic direction. Keating’s extensive career includes serving as CEO of TSX-V listed Giyani Metals, a key player in the manganese battery metals space, as well as leadership roles at Alufer Mining, Dynamic Mining, and ASX-listed Lindian Resources. A South African-qualified mining engineer, he started his career with Anglo American and Gold Fields, gaining hands-on expertise in production, project development, finance, and strategy. His experience extends into investment banking and corporate finance, having worked with Collins Stewart and ABN AMRO in London, where he specialized in project funding, mergers and acquisitions, and corporate strategy. With a strong technical and operational background, Keating has successfully managed technical studies, social and environmental assessments, and permitting processes. He holds a B.Sc. in Engineering (Mining) and is a Chartered Management Accountant. With Keating’s expertise, Aftermath Silver is well-positioned to advance its projects and strengthen its position in the evolving battery metals market. #proactiveinvestors #aftermathsilverltd #tsxv #aag #otcqx #aagff #mining #SilverMining, #BerenguelaProject, #Mining #Silver #Copper #Manganese #Peru #DrillingResults #BatteryMetals #ResourceModel #Investing #MiningUpdate #StrategicAdvisor #Manganese #EngineeringDevelopment

Proactive - Interviews for investors

Polarean Imaging chief business officer on potential of Xenon MRI pharma trials

Polarean Imaging PLC chief business officer Alex Dusek talked with Proactive's Stephen Gunnion about the company’s latest expansion into pharmaceutical-sponsored trials. This new initiative involves a multinational trial utilising Polarean’s Xenon MRI technology to assist drug development for lung diseases. Dusek explained that traditional lung function tests, such as spirometry, are crude and highly variable, making trials costly and time-consuming. Xenon MRI offers a more sensitive measurement, reducing variability and allowing drug companies to conduct trials with significantly fewer patients. "If you're designing a trial, let's say it's 25 to 50 patients with Xenon, that would take you 250 to 500 patients with the more traditional measures," he noted. Polarean is providing pharmaceutical companies with imaging biomarkers and harmonised data analysis, streamlining drug development. The company is also establishing a network of clinical sites equipped with Xenon MRI, creating an ecosystem that benefits sponsors, trial sites, and Polarean itself. Dusek highlighted Polarean’s partnership with VIDA Diagnostics, a well-known name in lung drug development, to further enhance the impact of this initiative. For more insights into Polarean Imaging’s latest developments, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for future updates. #PolareanImaging #XenonMRI #LungDisease #DrugDevelopment #ClinicalTrials #PharmaResearch #MedicalImaging #Biotech #HealthcareInnovation #Investing

Followers	2
Posts	1010
Boards Moderated	3
Alias Born	10/25/2024

Volume:	556,800
Day Range:	0.2316 - 0.2463
Bid:
Ask:
Last Trade Time:	8:00:00 PM EDT
Total Trades:	1,163

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

CVM Detailed Quote

Recent CVM News

More CVM News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent CVM News

Go Ad-Free